CDTX Historical PE Ratio image   This CDTX PE ratio history page last updated 1/22/2026
CDTX PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2025
11/6/2025
98.64-1.43-4.74NA
Q2 2025
8/7/2025
61.73-1.65-8.69NA
Q1 2025
5/8/2025
19.15-1.66-9.42NA
Q4 2024
3/6/2025
23.61-5.38-12.09NA
Q3 2024
11/7/2024
13.11-2.38-7.51NA
Q2 2024
8/13/2024
12.15-2.05-6.93NA
Q1 2024
5/15/2024
12.71-2.28-7.68NA
Q4 2023
4/22/2024
10.28-0.80-4.80NA
Q3 2023
11/2/2023
17.30-1.80-7.80NA
Q2 2023
8/3/2023
20.40-2.80-2.60NA
Q1 2023
5/11/2023
23.600.60-3.60NA
Q4 2022
3/23/2023
28.60-3.80-9.60NA
Q3 2022
11/3/2022
11.463.40-11.00NA
Q2 2022
8/9/2022
12.50-3.80-21.80NA
Q1 2022
5/11/2022
11.90-5.40-14.40NA
Q4 2021
3/7/2022
13.34-5.20-16.80NA
Q3 2021
11/10/2021
30.60-7.40-21.40NA
Q2 2021
8/12/2021
32.803.60-22.20NA
Q1 2021
5/13/2021
40.40-7.80-34.80NA
Q4 2020
2/25/2021
48.60-9.80-36.20NA
Q3 2020
11/5/2020
50.80-8.20-34.80NA
Q2 2020
8/13/2020
75.60-9.00-25.00NA
Q1 2020
5/13/2020
64.00-9.20-25.80NA
Q4 2019
3/4/2020
63.00-8.40-28.60NA
Q3 2019
11/7/2019
45.801.60-29.00NA
Q2 2019
8/8/2019
26.00-9.80-40.40NA
Q1 2019
5/9/2019
42.60-12.00-39.40NA
Q4 2018
2/28/2019
58.00-8.80-43.40NA
Q3 2018
11/8/2018
82.60-9.80-48.40NA
Q2 2018
8/8/2018
79.00-8.80-53.20NA
Q1 2018
5/10/2018
83.00-16.00-64.20NA
Q4 2017
2/27/2018
137.00-13.80-64.20NA
Q3 2017
11/8/2017
159.00-14.60-68.00NA
Q2 2017
8/9/2017
130.00-19.80-71.00NA
Q1 2017
5/10/2017
137.00-16.00-68.20NA
Q4 2016
3/15/2017
147.00-17.60-66.40NA
Q3 2016
11/10/2016
218.00-17.60-167.20NA
Q2 2016
8/11/2016
242.60-17.00NANA
Q1 2016
5/12/2016
229.80-14.20NANA
Q1 2015
5/21/2015
330.40-118.40NANA
CDTX Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2025
11/6/2025
98.64-1.43-5.72NA
Q2 2025
8/7/2025
61.73-1.65-6.60NA
Q1 2025
5/8/2025
19.15-1.66-6.64NA
Q4 2024
3/6/2025
23.61-5.38-21.52NA
Q3 2024
11/7/2024
13.11-2.38-9.52NA
Q2 2024
8/13/2024
12.15-2.05-8.20NA
Q1 2024
5/15/2024
12.71-2.28-9.12NA
Q4 2023
4/22/2024
10.28-0.80-3.20NA
Q3 2023
11/2/2023
17.30-1.80-7.20NA
Q2 2023
8/3/2023
20.40-2.80-11.20NA
Q1 2023
5/11/2023
23.600.602.409.8
Q4 2022
3/23/2023
28.60-3.80-15.20NA
Q3 2022
11/3/2022
11.463.4013.600.8
Q2 2022
8/9/2022
12.50-3.80-15.20NA
Q1 2022
5/11/2022
11.90-5.40-21.60NA
Q4 2021
3/7/2022
13.34-5.20-20.80NA
Q3 2021
11/10/2021
30.60-7.40-29.60NA
Q2 2021
8/12/2021
32.803.6014.402.3
Q1 2021
5/13/2021
40.40-7.80-31.20NA
Q4 2020
2/25/2021
48.60-9.80-39.20NA
Q3 2020
11/5/2020
50.80-8.20-32.80NA
Q2 2020
8/13/2020
75.60-9.00-36.00NA
Q1 2020
5/13/2020
64.00-9.20-36.80NA
Q4 2019
3/4/2020
63.00-8.40-33.60NA
Q3 2019
11/7/2019
45.801.606.407.2
Q2 2019
8/8/2019
26.00-9.80-39.20NA
Q1 2019
5/9/2019
42.60-12.00-48.00NA
Q4 2018
2/28/2019
58.00-8.80-35.20NA
Q3 2018
11/8/2018
82.60-9.80-39.20NA
Q2 2018
8/8/2018
79.00-8.80-35.20NA
Q1 2018
5/10/2018
83.00-16.00-64.00NA
Q4 2017
2/27/2018
137.00-13.80-55.20NA
Q3 2017
11/8/2017
159.00-14.60-58.40NA
Q2 2017
8/9/2017
130.00-19.80-79.20NA
Q1 2017
5/10/2017
137.00-16.00-64.00NA
Q4 2016
3/15/2017
147.00-17.60-70.40NA
Q3 2016
11/10/2016
218.00-17.60-70.40NA
Q2 2016
8/11/2016
242.60-17.00-68.00NA
Q1 2016
5/12/2016
229.80-14.20-56.80NA
Q1 2015
5/21/2015
330.40-118.40-473.60NA
Quotes delayed 20 minutes

Email EnvelopeFree CDTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cidara Therapeutics (CDTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CDXC PE Ratio History
CELC PE Ratio History
CELL PE Ratio History
CELU PE Ratio History
CEMI PE Ratio History
CERC PE Ratio History
CERE PE Ratio History
CERS PE Ratio History
CFMS PE Ratio History
CFRX PE Ratio History
On this page we presented the CDTX PE Ratio History information for Cidara Therapeutics' stock. The average CDTX PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 5.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CDTX PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CDTX PE ratio history result, against the recent PE: when this page was posted on 1/7/2026, the most recent closing price for CDTX had been 221.38, and the most recent quarterly earnings result, annualized, was 2.4. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CDTX PE on 1/7/2026 based on annualized quarterly EPS was 92.2. Based on CDTX's history, that recent PE is elevated relative to the historical average, with the recent PE 1744.0% higher than the historical average PE across our data set for Cidara Therapeutics.

For self directed investors doing their due diligence on CDTX or any other given stock, valuation analysis for CDTX can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cidara Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for CDTX. Thanks for visiting, and the next time you need to research CDTX PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: KMT Options Chain, STK YTD Return, LUCD Average Annual Return.

 

CDTX PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.